Karl Lewis, MD, discusses new and emerging treatments for metastatic melanoma.
Karl Lewis, MD, medical oncologist, associate professor, University of Colorado, discusses new and emerging treatments for metastatic melanoma.
Lewis says the list of new and emerging treatments for metastatic melanoma has grown due to the tremendous advancements in the field over the last couple of years.
In the immunotherapy field, Lewis says, ipilimumab showed a survival advantage for the first time in patients with melanoma. Progress is also being made with the development of PD-1 antibodies and PD-1 ligand antibodies.
There have also been developments in molecular targeted therapies, Lewis says. Agents targeting the RAS/RAF pathway, BRAF inhibitors and MEK inhibitors are in development as well. Lewis thinks the combination of BRAF plus MEK inhibitors is exciting.
Clinical Pearls
Brain Cancer Awareness Month: Challenges and Innovations in Treatment
May 13th 2024In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the blood-brain barrier.
Read More